False
In episode four, as we continue our focus on the digital, we look to DNDi’s use of the next-gen digital projects in open science.
The Medicine Maker presents a 6 episode series on the inspiring efforts of the Drugs for Neglected Diseases initiative. Tune in and learn just what it takes to develop medicines for some of the world’s most neglected patient populations.
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
April 4, 2022
We’re kicking off this mini-series with a very special guest: DNDi’s founder and fearless leader, Bernard Pécoul.
April 19, 2022
In this episode we look at DNDi’s work on mycetoma, an infection that inflicts disfigurement and disability on patients in rural, underserved regions.
May 2, 2022
As the series nears its midway point we are learning about DNDi’s Open Synthesis Network.
Discussing the use of different expression formats, from transient through to stable clones, when using Chinese Hamster Ovary cells for biotherapeutic protein production, experts from Lonza and Denmark Technical University share the key considerations of selecting an expression format during biotherapeutic development, and how Lonza’s GS Discovery® solution addresses these.
mRNA therapeutics manufacturing has been a major industrial talking point since its development during the COVID-19 pandemic. Now that CDMOs are developing the technologies and the capacities to scale it up, we find out just how much potential there is in this sector.
Conversations about drug formulation with experts from Merck, hosted by The Medicine Maker.
The Medicine Maker presents a 6 episode series on the inspiring efforts of the Drugs for Neglected Diseases initiative. Tune in and learn just what it takes to develop medicines for some of the world’s most neglected patient populations.
False